A convertible note of Novocure, an oncology company that develops and markets Tumor Treating Fields therapy, a device-based cancer treatment using electric fields.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 69 | Added +82% | 4,337,000 | $4,309,893 | 0.1% |
| Steve Cohen / Point72 | — | Trimmed -77% | 2,674 | $34,548 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.